Back to results
US 12,297,504 B2Granted
Chromosomal assessment to diagnose urogenital malignancy in dogs
AssigneeNorth Carolina State University
InventorMatthew Breen
Life of this patent
Estimating the term…
Abstract
This invention is directed to a method of diagnosing bladder cancer in dogs.
Claims9
A kit for detecting a urogenital malignancy in a dog, the kit comprising nucleic acid probes, primers, or pairs of primers, wherein the nucleic acid probes, primers, or pairs of primers consist of:
- a first nucleic acid probe, primer, or pair of primers capable of specifically detecting canine chromosome CFA 13 in a biological sample comprising neoplastic cells obtained from a dog;
- a second nucleic acid probe, primer, or pair of primers capable of specifically detecting canine chromosome CFA 19 in the biological sample;
- a third nucleic acid probe, primer, or pair of primers capable of specifically detecting canine chromosome CFA 36 in the biological sample;
- and optionally a fourth nucleic acid probe, primer, or pair of primers capable of specifically detecting a dog chromosome other than CFA 13, CFA 19, and CFA 36 and for measuring a copy number of the dog chromosome other than CFA 13, CFA 19, and/or CFA 36 to serve as a copy number control,
- and further wherein the first, second, and third, and optionally the fourth of nucleic acid probes, primers, or pairs of primers are differentially fluorescently labeled.
2 more elements
Dependencies are inferred from the claim text.